# Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients

> **NCT06861257** · — · RECRUITING · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 70 (estimated)

## Conditions studied

- Pediatric Hematopoietic Stem Cell Transplantation
- Malignant Disorders
- Non-malignant Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06861257
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-24
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06861257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06861257, "Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06861257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*